Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 16, 2022
Locally secreted BiTEs complement CAR T cells by enhancing killing of antigen heterogeneous solid tumorsYibo Yin, Jesse L Rodriguez, Nannan Li, et al.
Scientific Reports|February 28, 2024
Integrating imaging and genomic data for the discovery of distinct glioblastoma subtypes: a joint learning approachJun Guo, Anahita Fathi Kazerooni, Erik Toorens, et al.
Cancer|March 5, 2020
Histopathology-validated machine learning radiographic biomarker for noninvasive discrimination between true progression and pseudo-progression in glioblastomaHamed Akbari, Saima Rathore, Spyridon Bakas, et al.
Neuro-Oncology Advances|February 1, 2021
Multi-institutional noninvasive in vivo characterization of <i>IDH</i>, 1p/19q, and EGFRvIII in glioma using neuro-Cancer Imaging Phenomics Toolkit (neuro-CaPTk)Saima Rathore, Suyash Mohan, Spyridon Bakas, et al.
Scientific Reports|May 24, 2022
Clinical measures, radiomics, and genomics offer synergistic value in AI-based prediction of overall survival in patients with glioblastomaAnahita Fathi Kazerooni, Sanjay Saxena, Erik Toorens, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 22, 2022
Distinguishing Progression from Pseudoprogression in Glioblastoma Using <sup>18</sup>F-Fluciclovine PETAli Nabavizadeh, Stephen J Bagley, Robert K Doot, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2019
Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective StudyStephen J Bagley, S Ali Nabavizadeh, Jazmine J Mays, et al.
Science Translational Medicine|July 21, 2017
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastomaDonald M O'Rourke, MacLean P Nasrallah, Arati Desai, et al.
Communications Medicine|March 2, 2025
The radiogenomic and spatiogenomic landscapes of glioblastoma and their relationship to oncogenic driversAnahita Fathi Kazerooni, Hamed Akbari, Xiaoju Hu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 19, 2026
Metabolic Imaging and Molecular Signatures Reveal Metabolic Phenotypes in Recurrent GlioblastomaElizabeth J Li, Adam Kraya, Pedro Costa-Pinheiro, et al.
Pageof 9